4//SEC Filing
Litzka Olivier 4
Accession 0001933414-23-000026
CIK 0001933414other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:06 PM ET
Size
5.5 KB
Accession
0001933414-23-000026
Insider Transaction Report
Form 4
Litzka Olivier
Director
Transactions
- Other
Stock Option
2023-04-27−44,000→ 0 totalExercise: $16.00Exp: 2033-02-09→ Common Stock (44,000 underlying)
Footnotes (2)
- [F1]Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and BioDiscovery 6 FCPI.
- [F2]The stock option vests in 36 monthly installments beginning on March 9, 2023.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001963940
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:06 PM ET
- Size
- 5.5 KB